Clinical application of the Lung Cancer Compact PanelTM using various types of cytological specimens in patients with lung cancer
Open Access
- 3 February 2024
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 189, 107498
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 63 references indexed in Scilit:
- Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsyAnnals of Oncology, 2018
- Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trialThe Lancet Oncology, 2017
- Next-Generation Sequencing in Diagnostic PathologyPathobiology, 2017
- Tracking the Evolution of Non–Small-Cell Lung CancerNew England Journal of Medicine, 2017
- Guidelines for Validation of Next-Generation Sequencing–Based Oncology PanelsThe Journal of Molecular Diagnostics, 2017
- The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer stagingCA: A Cancer Journal for Clinicians, 2017
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceNew England Journal of Medicine, 2014
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarraysBMC Genomics, 2004